药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pentoxifylline
Perhexiline
The metabolism of Domperidone can be decreased when combined with Perhexiline.
Pentoxifylline
Panobinostat
The metabolism of Domperidone can be decreased when combined with Panobinostat.
Pentoxifylline
Osilodrostat
The metabolism of Domperidone can be decreased when combined with Osilodrostat.
Pentoxifylline
Lobeglitazone
The metabolism of Domperidone can be decreased when combined with Lobeglitazone.
Pentoxifylline
Simeprevir
The metabolism of Domperidone can be decreased when combined with Simeprevir.
Pentoxifylline
Alosetron
The metabolism of Domperidone can be decreased when combined with Alosetron.
Pentoxifylline
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Domperidone.
Pentoxifylline
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Domperidone.
Pentoxifylline
Lopinavir
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Domperidone.
Pentoxifylline
Digitoxin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Domperidone.
Pentoxifylline
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Domperidone.
Pentoxifylline
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Domperidone.
Pentoxifylline
Mepyramine
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Domperidone.
Pentoxifylline
Metoclopramide
The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Domperidone.
Pentoxifylline
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Domperidone.
Pentoxifylline
Aripiprazole lauroxil
The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Domperidone.
Pentoxifylline
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Domperidone.
Pentoxifylline
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Domperidone.
Pentoxifylline
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Domperidone.
Pentoxifylline
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Domperidone.